An Antisense Construct Reduces N-Methyl-D-Aspartate Receptor 2A Expression and Receptor-Mediated Excitotoxicity as Determined by a Novel Flow Cytometric Approach

Journal of Neuroscience Research

Volumn 74, Issue 5, 2003, Pages 782-793

  Mattar, Pierre A ^b   Holmes, Kevin D ^b   Dekaban, A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

Antisense; Excitotoxicity; Flow cytometry; Green fluorescent protein; N methyl D aspartate receptor

Indexed keywords

HYBRID PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; YELLOW FLUORESCENT PROTEIN;

ARTICLE; CELL CULTURE; FLOW CYTOMETRY; GENE CONSTRUCT; HUMAN; HUMAN CELL; NEUROTOXICITY; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BACTERIAL PROTEINS; CELL LINE; DNA, ANTISENSE; EMBRYO; FLOW CYTOMETRY; HEPATOCYTES; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 0344430260     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10793     Document Type: Article

References (62)

1. Anegawa NJ, Guttmann RP, Grant ER, Anand R, Lindstrom J, Lynch DR. 2000. N-methyl-D-aspartate receptor mediated toxicity in nonneuronal cell lines: characterization using fluorescent measures of cell viability and reactive oxygen species production. Brain Res Mol Brain Res 77: 163-175.
2. Anegawa NJ, Lynch DR, Verdoorn TA, Pritchett DB. 1995. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death. J Neurochem 64:2004-2012.
3. Baker BF, Monia BP. 1999. Novel mechanisms for antisense-mediated regulation of gene expression. Biochim Biophys Acta 1489:3-18.
4. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
5. Cheli VT, Adrover MF, Blanco C, Rial Verde E, Guyot-Revol V, Vidal R, Martin E, Alche L, Sanchez G, Acerbo M, Epstein AL, Jerusalinsky D. 2002. Gene transfer of NMDAR1 subunit sequences to the rat CNS using herpes simplex virus vectors interfered with habituation. Cell Mol Neurobiol 22:303-314.
6. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. 1998. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22:295-299.
7. Ciabarra AM, Sullivan JM, Gahn LG, Pecht G, Heinemann S, Sevarino KA. 1995. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J Neurosci 15:6498-6508.
8. Crooke ST. 1999. Molecular mechanisms of action of antisense drugs. Biochim Biophys Acta 1489:31-44.
9. Cull-Candy S, Brickley S, Farrant M. 2001. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11:327-335.
10. Dingledine R, Borges K, Bowie D, Traynelis SF. 1999. The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
11. Doble A. 1999. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81:163-221.
12. Eide PK. 1998. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury. Spinal Cord 36:601-612.
13. Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800.
14. Finegold AA, Perez FM, Iadarola MJ. 2001. In vivo control of NMDA receptor transcript level in motoneurons by viral transduction of a short antisense gene. Brain Res Mol Brain Res 90:17-25.
15. Fukaya M, Kato A, Lovett C, Tonegawa S, Watanabe M. 2003. Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice. Proc Natl Acad Sci USA 100:4855-4860.
16. Garcia-Gallo M, Renart J, Diaz-Guerra M. 2001. The NR1 subunit of the N-methyl-D-aspartate receptor can be efficiently expressed alone in the cell surface of mammalian cells and is required for the transport of the NR2A subunit. Biochem J 356:539-547.
17. Goebel DJ, Poosch MS. 1999. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NK1Com, NK2A, NK2B, NK2C, NK2D and NK3A. Brain Res Mol Brain Res 69:164-170.
18. Guttmann RP, Baker DL, Seifert KM, Cohen AS, Coulter DA, Lynch DR. 2001. Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem 78:1083-1093.
19. Hewitt DJ. 2000. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 16(Suppl):73-79.
20. Holmes KD, Cassam AK, Chan B, Peters AA, Weaver LC, Dekaban GA. 2000. A multi-mutant herpes simplex virus vector has minimal cytotoxic effects on the distribution of filamentous actin, alpha-actinin 2 and a glutamate receptor in differentiated PC12 cells. J Neurovirol 6:33-45.
21. Holmes KD, Mattar PA, Marsh DR, Weaver LC, Dekaban GA. 2002a. The N-methyl-D-aspartate receptor splice variant NR1-4 C-terminal domain. Deletion analysis and role in subcellular distribution, J Biol Chem 277:1457-1468.
22. Holmes KD, Mattar P, Marsh DR, Jordan V, Weaver LC, Dekaban GA. 2002b. The C-terminal C1 cassette of the N-methyl-D-aspartate receptor 1 subunit contains a bi-partite nuclear localization sequence. J Neurochem 81:1152-1165.
23. Huh KH, Wenthold RJ. 1999. Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem 274:151-157.
24. Inagaki N, Kuromi H, Gonoi T, Okamoto Y, Ishida H, Seino Y, Kaneko T, Iwanaga T, Seino S. 1995. Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB J 9:686-691.
25. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M, Nakanishi S. 1993. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
26. Jarvis TC, Wincott FE, Alby LJ, McSwiggen JA, Beigelman L, Gustofson J, DiRenzo A, Levy K, Arthur M, Matulic-Adamic J, Karpeisky A, Gonzalez C, Woolf TM, Usman N, Stinchcomb DT. 1996. Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. J Biol Chem 271:29107-29112.
27. Kohl BK, Dannhardt G. 2001. The NMDA receptor complex: a promising target for novel antiepileptic strategies. Curr Med Chem 8:1275-1289.
28. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. LeVatte MA, Cassam AK, Dekaban GA, Weaver LC. 1998. Analysis of a multi-mutant herpes simplex virus type 1 for gene transfer into sympathetic preganglionic neurons and a comparison to adenovirus vectors. Neuroscience 86:1321-1336.
30. LeVatte MA, Dekaban GA, Weaver LC. 1997. Gene transfer into sympathetic preganglionic neurons in vivo using a non-replicating thymidine kinase-deficient herpes simplex virus type 1. Neuroscience 80:893-906.
31. Lieberman DN, Mody I. 1999. Casein kinase-II regulates NMDA channel function in hippocampal neurons. Nat Neurosci 2:125-132.
32. Lloyd BH, Giles RV, Spiller DG, Grzybowski J, Tidd DM, Sibson DR. 2001. Determination of optimal sites of antisense oligonucleotide cleavage within TNFα mRNA. Nucleic Acids Res 29:3664-3673.
33. Lombardi G, Dianzani C, Miglio G, Canonico PL, Fantozzi R. 2001. Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol 133:936-944.
34. Luo JH, Fu ZY, Losi G, Kim BG, Prybylowski K, Vissel B, Vicini S. 2002. Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture. Neuropharmacology 42:306-318.
35. Maiorov DN, Krenz NR, Krassioukov AV, Weaver LC. 1997. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats. Am J Physiol 273:1266-1274.
36. Malenka RC, Nicoll RA. 1999. Long-term potentiation - a decade of progress? Science 285:1870-1874.
37. Marshall J, Molloy R, Moss GW, Howe JR, Hughes TE. 1995. The jellyfish green fluorescent protein: a new tool for studying ion channel expression and function. Neuron 14:211-215.
38. Minami T, Sugatani J, Sakimura K, Abe M, Mishina M, Ito S. 1997. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. Br J Pharmacol 120:1522-1526.
39. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
40. Morikawa E, Mori H, Kiyama Y, Mishina M, Asano T, Kirino T. 1998. Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. J Neurosci 18:9727-9732.
41. Nishi M, Hinds H, Lu HP, Kawata M, Hayashi Y. 2001. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21:185.
42. Nishizawa Y. 2001. Glutamate release and neuronal damage in ischemia. Life Sci 69:369-381.
43. Ozawa S, Kamiya H, Tsuzuki K. 1998. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581-618.
44. Parsons G. 2001. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharm 429:71-78.
45. Pierce ML, Ruffner DE. 1998. Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition. Nucleic Acids Res 26:5093-5101.
46. Prybylowski K, Fu Z, Losi G, Hawkins LM, Luo J, Chang K, Wenthold RJ, Vicini S. 2002. Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci 22:8902-8910.
47. Sasaki YF, Rothe T, Premkumar LS, Das S, Cui J, Talantova MV, Wong HK, Gong X, Chan SF, Zhang D, Nakanishi N, Sucher NJ, Lipton SA. 2002. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol 87:2052-2063.
48. Scherr M, Reed M, Huang CF, Riggs AD, Rossi JJ. 2000. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyl-transferase. Mol Ther 2:26-38.
49. Sheng M, Kim MJ. 2002. Postsynaptic signaling and plasticity mechanisms. Science 298:776-780.
50. Shi Y. 2003. Mammalian RNAi for the masses. Trends Genet 19:9-12.
51. Sohail M, Hochegger H, Klotzbucher A, Guellec RL, Hunt T, Southern EM. 2001. Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo. Nucleic Acids Res 29:2041-2051.
52. Sprengel R, Single FN. 1999. Mice with genetically modified NMDA and AMPA receptors. Ann N Y Acad Sci 868:494-501.
53. Tatout C, Gauthier E, Pinon H. 1998. Rapid evaluation in Escherichia coli of antisense RNAs and ribozymes. Lett Appl Microbiol 27:297-301.
54. Vazhappilly R, Sucher NJ. 2002. Turnover analysis of N-methyl-D-aspartate receptor subunit NR1 protein in PC12 cells. Neurosci Lett 318:153-157.
55. Wagey R, Hu J, Pelech SL, Raymond LA, Krieger C. 2001. Modulation of NMDA-mediated excitotoxicity by protein kinase C. J Neurochem 78: 715-726.
56. Wang Y, TesFaye E, Yasuda RP, Mash DC, Armstrong DM, Wolfe BB. 2000. Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain. Brain Res Mol Brain Res 80:123-131.
57. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC. 1999. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 96:3211-3216.
58. Wood MW, VanDongen HM, VanDongen AM. 1996. The 5′-untranslated region of the N-methyl-D-aspartate receptor NR2A subunit controls efficiency of translation. J Biol Chem 271:8115-8120.
59. Wrzesinski J, Legiewicz M, Ciesiolka J. 2000. Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes. Nucleic Acids Res 28:1785-1793.
60. Xing Z, Whitton JL. 1992. Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure. J Virol 66:1361-1369.
61. Yu Q, Pecchia DB, Kingsley SL, Heckman JE, Burke JM. 1998. Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules. J Biol Chem 273:23524-23533.
62. Zhao JJ, Lemke G. 1998. Rules for ribozymes. Mol Cell Neurosci 11:92-97.